You are here

Article info

Article menu
Download PDFPDF
PostScript
Letter
Application of the CSF JCV antibody index to early natalizumab-associated progressive multifocal leukoencephalopathy

Authors

  • Clemens Warnke Department of Neurology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany Department of Neurology, University Hospital Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  • Martijn T Wijburg Department of Radiology & Nuclear Medicine, Neuroscience Amsterdam, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Neurology, Neuroscience Amsterdam, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Hans-Peter Hartung Department of Neurology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany PubMed articlesGoogle scholar articles
  • Joep Killestein Department of Neurology, Neuroscience Amsterdam, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Ortwin Adams Institute for Virology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany PubMed articlesGoogle scholar articles
  • Mike P Wattjes Department of Radiology & Nuclear Medicine, Neuroscience Amsterdam, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Clemens Warnke, Department of Neurology, University Hospital Cologne, Kerpener Strasse 62, Cologne 50937, Germany; clemens.warnke{at}uk-koeln.de
View Full Text

Citation

Warnke C, Wijburg MT, Hartung H, et al
Application of the CSF JCV antibody index to early natalizumab-associated progressive multifocal leukoencephalopathy
Journal of Neurology, Neurosurgery & Psychiatry 2017;88:1092-1094.

Publication history

  • Received November 16, 2016
  • Revised April 4, 2017
  • Accepted April 9, 2017
  • First published May 10, 2017.
Online issue publication 
December 12, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.